KORU Medical Systems (NASDAQ:KRMD) CFO Thomas Edward Adams Purchases 5,500 Shares of Stock

KORU Medical Systems, Inc. (NASDAQ:KRMD) CFO Thomas Edward Adams purchased 5,500 shares of the company’s stock in a transaction on Thursday, May 14th. The stock was acquired at an average cost of $3.86 per share, for a total transaction of $21,230.00. Following the completion of the purchase, the chief financial officer owned 308,147 shares of the company’s stock, valued at approximately $1,189,447.42. This trade represents a 1.82% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

KORU Medical Systems Stock Performance

Shares of KRMD opened at $3.83 on Tuesday. KORU Medical Systems, Inc. has a 52-week low of $2.63 and a 52-week high of $6.61. The business’s 50 day moving average price is $4.22 and its two-hundred day moving average price is $4.84. The firm has a market cap of $175.91 million, a PE ratio of -76.60 and a beta of 0.43.

KORU Medical Systems (NASDAQ:KRMD) last issued its quarterly earnings results on Wednesday, May 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.02). KORU Medical Systems had a negative return on equity of 13.61% and a negative net margin of 5.27%.The firm had revenue of $11.76 million for the quarter, compared to analyst estimates of $11.28 million. Research analysts predict that KORU Medical Systems, Inc. will post -0.03 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have issued reports on KRMD shares. B. Riley Financial boosted their price target on KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research note on Friday, March 13th. Wall Street Zen lowered KORU Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Canaccord Genuity Group reissued a “buy” rating and issued a $6.00 price target on shares of KORU Medical Systems in a research note on Friday, March 13th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Tuesday, April 21st. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $7.25.

Institutional Investors Weigh In On KORU Medical Systems

Several hedge funds and other institutional investors have recently modified their holdings of KRMD. BNP Paribas Financial Markets increased its holdings in shares of KORU Medical Systems by 52.1% during the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after acquiring an additional 3,478 shares in the last quarter. Lazard Asset Management LLC bought a new stake in shares of KORU Medical Systems during the second quarter valued at approximately $59,000. Acadian Asset Management LLC bought a new stake in shares of KORU Medical Systems during the first quarter valued at approximately $63,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of KORU Medical Systems during the first quarter valued at approximately $79,000. Finally, Invesco Ltd. bought a new stake in shares of KORU Medical Systems during the second quarter valued at approximately $80,000. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.